AstraZeneca is to acquire Novexel, the French infection research company, for up to £266m, and will collaborate with US-based Forest Laboratories in the development of two antibiotics. [31-Dec-2009]
Granville Oil & Chemicals has secured £1m of funding from the Co-operative Bank to acquire its 34,000 sq ft factory building in Rotherham, and has also acquired the UK manufacturing rights for the Gunk brand. [21-Dec-2009]
Cobra Biomanufacturing, the Keele-based vaccine manufacturer with 80 staff, has recommended a takeover bid from Recipharm of Sweden that values the company at about £1m. [21-Dec-2009]
Lab21 has acquired Selah Technologies, the US nanotechnology company, for undisclosed terms. [21-Dec-2009]
Avecia Biologics, the Billingham-based biotechnology company with 500 staff, is to be acquired by Merck for undisclosed terms. [21-Dec-2009]
GlaxoSmithKline has confirmed that its Barnard Castle site is one of three potential locations for a new £300m biopharmaceuticals factory, which could create hundreds of jobs. [21-Dec-2009]
Genetix Group, the cell imaging company with sites in Hampshire and Gateshead, is to be acquired by Danaher Corp of the US for £63m. [21-Dec-2009]
TrichoTech is planning to expand the workforce at its Cardiff-based drug and alcohol testing business from 50 to 60 early next year. [17-Dec-2009]
Silence Therapeutics is to acquire Intradigm, the US biotechnology company specialising in experimental medicines based on RNA interference, for £16m. [17-Dec-2009]
McBride has acquired Homepride, the Milton Keynes-based supplier of cleaning products, for undisclosed terms. [17-Dec-2009]
Alberto Culver is to acquire the Simple skin care brand in the UK from Duke Street for £240m. [15-Dec-2009]
PPG is to shed 83 jobs at its paints and coatings business in Birstall and Morley by the end of the year. [15-Dec-2009]
Pentagon Chemicals has secured a £2m investment from Maven Capital Partners to fund the expansion of its chemicals business, which has 160 staff in Cheshire and Cumbria. [14-Dec-2009]
Circassia of Oxford has raised £15m to fund the development of allergy treatments. [14-Dec-2009]
Scottish Enterprise has announced government funding of £24m for the development of a "bioincubator" in Edinburgh's BioQuarter, in order to create up to 200 jobs in the biotechnology sector over the next five years. [10-Dec-2009]
Verona Pharma is to raise £3m in a share placing to fund the commercial development of a new treatment for asthma. [09-Dec-2009]
Marken is to sell a majority stake in its London-based pharmaceuticals support services business to private equity firm Apax Partners in a £975m deal. [08-Dec-2009]
Reckitt Benckiser is to relocate 90 office-based jobs from Hull to Slough over the next few months. [07-Dec-2009]
Phytopharm is to raise £25m in a share placing to fund the commercial development of its plant-based pharmaceutical products. [07-Dec-2009]
Exwold is planning to set up a new 8,000 sq ft crop protection chemicals plant on the Queens Meadow Business Park in Hartlepool, and also hopes to open a factory in Brazil. [03-Dec-2009]
AstraZeneca is planning to transfer production of active pharmaceutical ingredients from the UK to China over the next few years, which could lead to job losses at a plant near Bristol. [30-Nov-2009]
Lab21 has acquired the business and assets of Delphic Diagnostics, the laboratory services firm with sites in Liverpool and Kent, out of administration for undisclosed terms. [30-Nov-2009]
Ineos Chlor Vinyls has announced plans for a multi-million pound investment in the expansion of its chloromethane production plant in Runcorn over the next five years. [30-Nov-2009]
Intercytex has closed its operation in Cambridge, as part of a restructuring of its stem cell business which includes the sale of its Axordia subsidiary to Pfizer for £0.5m. [25-Nov-2009]
Ashfield In2Focus is to invest £7m in the expansion of the Ashby-based headquarters of its pharmaceutical training business, with the creation of up to 50 jobs, including the relocation of its Universal Procon division from Slough. [25-Nov-2009]
Clariant, the Swiss chemicals company, has announced plans to shed a further 570 jobs and close plants in Pontypridd, France and Mexico. [23-Nov-2009]
Epistem is to raise £2.9m in a share placing to fund the expansion of its Manchester-based biotechnology business. [23-Nov-2009]
Plethora Solutions is to raise £1.6m in a share placing to fund the creation of a new subsidiary to supply therapeutic products to urology clinics. [19-Nov-2009]
Orthomimetics, the Cambridge-based regenerative medicine firm with 11 staff, has been acquired by TiGenix of Belgium for £14m. [18-Nov-2009]
Bristol-Myers Squibb is investing a further £3.5m in the expansion of its pharmaceuticals research and development centre in Wirral, in order to create new laboratories and secure 100 jobs. [18-Nov-2009]
Conformetrix, the Manchester-based drug development company, has secured an undisclosed equity investment from the Aquarius Origin Fund and aims to expand its workforce from five to 15 by 2011. [18-Nov-2009]
ScriptSwitch, the Coventry-based provider of drug comparison software to doctors with 45 staff, is to be acquired by UnitedHealth of the US. [18-Nov-2009]
Futura Medical is to raise £1.5m in a share placing to provide additional working capital and to evaluate research leads for its Guildford-based pharmaceuticals business. [16-Nov-2009]
GlaxoSmithKline is planning to consolidate production of dermatology products at sites in Barnard Castle and Canada, but four recently-acquired Stiefel sites in the US and Ireland could close. [16-Nov-2009]
Smith & Nephew is to acquire the assets of Nucryst Pharmaceuticals, the US manufacturer of antimicrobial dressings, for £13m. [12-Nov-2009]
Quay Pharma is to relocate from Bromborough to a new £2.7m pharmaceuticals research and development centre at Deeside Industrial Park in Flintshire in January, with the creation of 54 jobs. [11-Nov-2009]
Pfizer is to close its pharmaceutical research departments in Slough and Gosport next year, with the loss of 90 jobs. [11-Nov-2009]
Catalent Pharma Solutions is to shed 275 jobs at its pharmaceutical capsules factory in Swindon over the next two years. [10-Nov-2009]
One North East has announced that INEOS Bio is conducting a £3.5m feasibility study into the development of a waste-fuelled bioethanol plant at Seal Sands in the Tees Valley. [09-Nov-2009]
E-Therapeutics has raised £2.5m in a share placing to fund the expansion of its drug discovery business. [04-Nov-2009]
Phoenix Chemicals has secured a Scottish Government grant to reopen the former Shasun pharmaceutical chemicals plant in Annan, as part of a £4m investment that will create 58 jobs over the next three years. [02-Nov-2009]
Brunner Mond is planning to build a sustainable energy plant fuelled by biomass and pre-treated waste at its chemicals site in Lostock, Cheshire, in partnership with Eon. [29-Oct-2009]
SCM Pharma is looking to expand the workforce at its Northumberland-based pharmaceuticals production business from 43 to almost 70 next year. [27-Oct-2009]
Duke Street Capital is looking to sell Simple, the Solihull-based supplier of sensitive skin products with 55 staff, for more than £250m. [26-Oct-2009]
Forensic Science Service has confirmed plans to close three laboratories in Chorley, Chepstow and Birmingham, with the loss of up to 700 jobs. [26-Oct-2009]
Avacta Group is to raise £2m in a share placing to fund the expansion of its York-based pharmaceuticals and diagnostic tests business. [26-Oct-2009]
Ranbaxy Laboratories is to relocate the London headquarters of its pharmaceuticals business from Ealing to a 5,000 sq ft office at Chiswick Park. [22-Oct-2009]
Parkwood has acquired full ownership of its Exeter-based Verdia horticultural compost manufacturing joint venture from TEG Group. [20-Oct-2009]
Retroscreen Virology has secured £2.6m of venture capital funding to increase capacity at its London-based vaccines research business. [15-Oct-2009]
GlaxoSmithKline is to provide land and facilities worth £11m to a joint venture with the government and Wellcome Trust to build a new £37m bioscience campus in Stevenage, which could create up to 1,500 jobs. [14-Oct-2009]
Sinclair Pharma has acquired the Flammazine and Flammacerium dermatology products from Solvay Pharmaceuticals for £16m. [13-Oct-2009]
Oncimmune of Nottingham is seeking £12m of funding for the commercial development of its cancer detection technology. [12-Oct-2009]
Ineos Compounds is to close its PVC compounds operation in Runcorn with the loss of an unspecified number of jobs, in order to transfer production to Newton Aycliffe. [12-Oct-2009]
New Horizons Global is planning to expand the 18-strong workforce at its biotechnology operation in Knowsley to 60 over the next year, following a £1.4m investment in the production of omega-3 oil. [08-Oct-2009]
Third Coast Chemicals of the US is to seek government support to invest £50m in the overhaul of a former ICI chemicals plant at Wilton on Teesside, in order to produce diethylene and triethylene glycol. [05-Oct-2009]
Advanced Medical Solutions has acquired the remaining 51% of Corpura, the Dutch supplier of wound dressings with 15 staff, for £2m. [05-Oct-2009]
Quintiles Transnational Corp is creating a further 150 jobs at its new 115,000 sq ft biopharmaceutical services site in Livingston. [05-Oct-2009]
Thornton & Ross has acquired Zeroderma, the Leicestershire-based supplier of dermatological creams, for undisclosed terms. [01-Oct-2009]
Unilever is to acquire the personal care division of Sara Lee for £1.2bn, including a bath products factory in Slough that employs 300. [28-Sep-2009]
Consort Medical is to acquire The Medical House, the Sheffield-based drug injection firm, for about £16m. [28-Sep-2009]
Mawdsley Brooks has expanded its Salford-based pharmaceuticals wholesaling business with the acquisition of Midlands-based National Generics and Scotland-based Eclipse Generics. [28-Sep-2009]
Almac Laboratories has secured planning permission for the multi-million pound expansion of its pharmaceutical operations in Portadown, which will lead to the creation of up to 500 jobs. [28-Sep-2009]
LifeScan has secured a £2m Scottish Government grant to produce a new blood glucose monitoring system in Inverness, safeguarding the future of 223 jobs. [28-Sep-2009]
DxS, the Manchester-based manufacturer of genetic testing kits with 90 staff, has been acquired by Qiagen of Germany for up to £79m, and will soon relocate to a larger site at Manchester Science Park. [24-Sep-2009]
Provexis is in discussions to raise £5m from investors to fund the expansion of its biotechnology operations in Windsor and Liverpool. [24-Sep-2009]
Cancer Research UK is providing £8m for the development of a drug discovery centre in Manchester, while £8m will go to the Beatson Institute in Glasgow and £5m to Oxford and Southampton universities. [23-Sep-2009]
The University of Liverpool has submitted plans to build a £90m cancer research centre in Crown Street by 2011. [22-Sep-2009]
Martindale Pharmaceuticals has been put up for sale by US parent Cardinal Health, with an estimated price tag of £150m. [21-Sep-2009]
Excalibur has acquired International Biosciences Managers, the biotechnology advisory and fund management firm, for undisclosed terms. [21-Sep-2009]
Renovo is planning to shed up to one third of the 180 jobs at its Manchester-based biotechnology business, in order to focus on the development of anti-scarring drugs. [21-Sep-2009]
Eli Lilly is planning to shed 5,500 jobs from its global pharmaceuticals workforce, which could affect some of the 1,600 staff in Windlesham, Speke and Basingstoke. [15-Sep-2009]
Randox Laboratories is to create a further 34 jobs at its biotechnology business in County Antrim. [14-Sep-2009]
International Flavours & Fragrances is planning to shed up to 50 of the 300 jobs at its chemical ingredients factory in Haverhill. [14-Sep-2009]
Phoenix Chemicals has acquired the former Shasun Pharma Solutions pharmaceuticals plant near Annan in Dumfries & Galloway for undisclosed terms, which could lead to the creation of about 70 jobs. [10-Sep-2009]
Jotun Paints (Europe) is planning a multi-million pound expansion of its paints factory in Flixborough, with the creation of an unspecified number of jobs. [10-Sep-2009]
Myconostica has raised a further £1.7m of venture capital to fund the expansion of its Manchester-based medical diagnostics business. [09-Sep-2009]
Dechra is to invest £1m in the expansion of its animal medicines site in Talke, North Staffordshire, including a new warehouse on the Jamage Industrial Estate. [08-Sep-2009]
Lab901 has raised a further £2.4m from investors to fund the expansion of its Edinburgh-based laboratory testing systems business. [07-Sep-2009]
Summit Corporation has sold its Dextra Laboratories chemistry services division to New Zealand Pharmaceuticals for £1m, in order to focus on its Oxfordshire-based drug discovery business. [03-Sep-2009]
The University of Liverpool has unveiled plans to build a new £25m science laboratory on Chatham Street North by September 2011. [02-Sep-2009]
ProStrakan has sold the US distribution rights for its Fortigel testosterone gel to Endo Pharmaceuticals for £30m. [27-Aug-2009]
Synexus of Chorley has acquired CLCC, the operator of three clinical trial centres in Poland. [27-Aug-2009]
Alliance Pharma is to acquire the worldwide rights to the Buccastem and Timodine prescription brands from Reckitt Benckiser for £7.5m. [20-Aug-2009]
Nova Laboratories is to set up a new £2m factory to manufacture bone cement for hip replacements near its existing site in Leicestershire by December, with the creation of up to 60 jobs. [19-Aug-2009]
Aptuit is to shed an unspecified number of the 200 jobs at its pharmaceuticals research and packaging facility on the Deeside industrial park. [18-Aug-2009]
North Lincolnshire Council is supporting John Carson Innovations in the development of a new Limelite fertiliser pellets factory in Bonby, with the creation of 24 jobs. [17-Aug-2009]
York Pharma, the Milton Keynes-based pharmaceuticals company, has been bought out of administration by RH Acquisitions. [11-Aug-2009]
Celsis International, the laboratory services company, is to be acquired by Nastor Investments for £54m. [04-Aug-2009]
AstraZeneca is planning to relocate its London headquarters from Mayfair to a 60,000 sq ft office in Paddington next year. [04-Aug-2009]
The Institute for Animal Health has secured a £100m government grant to build new laboratories at its site in Pirbright, Surrey. [04-Aug-2009]
Aesica is to invest £5m in the expansion of its pharmaceuticals research centre in Cramlington over the next three years, and is now looking to recruit up to 30 scientists. [04-Aug-2009]
Union Colours has bought the Stockport-based technical centre of European Colour Pigments out of administration for undisclosed terms, securing 15 jobs. [04-Aug-2009]
Reckitt Benckiser is to invest £13m in new health care manufacturing facilities at its site in Hull, with the creation of 60 jobs. [04-Aug-2009]
BASF is to close the Ciba chemicals headquarters in Macclesfield next year, with the loss of about 100 jobs, in order to transfer the work to its site in Cheadle Hulme. [21-Jul-2009]
The Department for Business Innovation & Skills is to invest £12m in a new industrial biotechnology demonstrator facility at Wilton on Teesside by next year, with the creation of up to 40 jobs. [20-Jul-2009]
Swansea University has secured funding of £30m to expand its medical research institute by 2011, with the creation of up to 650 jobs. [20-Jul-2009]
Animalcare is looking to spend up to £10m on acquisitions to expand its North Yorkshire-based pet drugs business. [13-Jul-2009]
Everbuild Building Products has acquired Feb, the Manchester-based manufacturer of building chemicals, and production will transfer to Everbuild's factory in Leeds. [13-Jul-2009]
ICON has acquired Veeda Laboratories, the Oxford-based supplier of biomarker laboratory services, from Veeda Clinical Research. [13-Jul-2009]
Randox Laboratories has announced plans for a £9.2m investment in research and development at its Northern Ireland-based chemical diagnostics business, including a £3.1m grant from Invest NI. [13-Jul-2009]
Dow Chemical and Croda International are to close their ethylene oxide and glycol operations at Wilton on Teesside next January, with the loss of up to 170 jobs. [09-Jul-2009]
Ciba is to shed about 150 of the 830 jobs at its speciality chemicals plant in Bradford, following its acquisition by BASF, in order to transfer research work to Germany. [08-Jul-2009]
Sanofi Aventis is said to be seeking a buyer for its pharmaceuticals research and development site in Alnwick, Northumberland, which has 170 staff. [02-Jul-2009]
Croda has confirmed plans to shed about 100 jobs at the Wilton Centre on Teesside, in order to transfer its chemicals research, finance, sales and administration work to sites in Hull, Widnes and Snaith. [01-Jul-2009]
The Scottish Government is to provide funding of £3m to enable life sciences companies to employ 100 apprentices, and the initiative will be implemented by Skills Development Scotland. [30-Jun-2009]
Eisai has opened its new £100m pharmaceuticals manufacturing and research facility in Hatfield, which will create 250 research jobs. [29-Jun-2009]
Quotient Bioresearch is to acquire the Amersham Radiolabeling Services laboratories in Cardiff, in a £15m deal that will secure 75 jobs and create 40 new jobs. [29-Jun-2009]
Wellcome Trust has announced funding of £41m for four new medical engineering centres of excellence at Imperial College London, King's College London, the University of Oxford and the University of Leeds. [25-Jun-2009]
Dow Chemical is said to be in negotiations to sell its ethylene oxide plant on Teesside to Third Coast Chemicals of the US. [25-Jun-2009]
Chroma Therapeutics of Oxfordshire has agreed a deal worth up to £750m with GlaxoSmithKline to develop new drugs for inflammatory disorders. [25-Jun-2009]
Brotherton Speciality Products is to invest £4m in the expansion of its sulphites production facility in Wakefield. [23-Jun-2009]
ICON and the Central Manchester University Hospitals Foundation Trust are to set up a pharmaceuticals research facility at the Manchester Royal Infirmary by 2012. [18-Jun-2009]
Allergy Therapeutics is to raise up to £22m in a share placing, in order to invest in European sales and marketing for its pharmaceuticals business. [15-Jun-2009]
Concateno, the drug and alcohol testing company with sites in Abingdon, London, Cardiff and Spain, is to be acquired by Inverness Medical Innovations in a £147m deal. [08-Jun-2009]
ICI is considering locations in Bracknell, Reading and Slough for a new 140,000 sq ft headquarters for its paint manufacturing business. [08-Jun-2009]
Proximagen Neuroscience has raised £50m in a share placing, in order to fund the expansion of its London-based drug development business. [08-Jun-2009]
Ineos has secured a £7.6m Scottish Government grant to go towards a £65m investment at the Grangemouth refinery and petrochemicals complex, which will help to secure more than 500 jobs. [04-Jun-2009]
Reckitt Benckiser is to relocate about 100 sales, marketing and finance jobs from Swindon to its head office in Slough. [28-May-2009]
MacDermid is creating up to 100 jobs at its new £15m chemicals research and development laboratory in Small Heath, Birmingham. [25-May-2009]
Lab21 has acquired Plasmatec Laboratory Products, the Dorset-based diagnostic tests manufacturer, from Axis-Shield for undisclosed terms. [21-May-2009]
University of Central Lancashire has unveiled plans to invest £12m in the expansion of its forensic and pharmaceutical sciences facility in Preston. [20-May-2009]
Alliance Boots is to reorganise its pharmaceutical wholesaling division with the loss of up to 1,500 jobs, including 200 in the UK. [19-May-2009]
AstraZeneca has awarded a £45m contract to Mott MacDonald to build a four-storey research centre at its Alderley Park site in Cheshire. [18-May-2009]
Celanese is to shed about 100 of the 525 jobs at its chemicals plant in Derby. [14-May-2009]
PharmaNet, the pharmaceuticals company, is said to be seeking a suitable 20,000 sq ft office in the High Wycombe area. [11-May-2009]
The Specials Laboratory is planning to expand the 135-strong workforce at its pharmaceuticals business in Prudhoe, Northumberland, to 150 over the next year. [11-May-2009]
Forensic Science Service is considering plans to close its laboratory in Chepstow with the loss of up to 200 jobs, and other sites could also be affected as part of the competitive tendering process for forensic services. [11-May-2009]
Summit Corporation has sold its Oxfordshire-based Zebrafish services division to Evotec for £0.5m, in order to focus on its drug discovery operation. [07-May-2009]
Semiramis Genetics is to set up a new headquarters for its life sciences business at the Manchester Science Park in June. [07-May-2009]
Genetix Group has acquired SlidePath, the Irish cell imaging firm with 25 staff, for up to £3.3m. [30-Apr-2009]
SABIC is planning to close its thermoplastics plant in Grangemouth with the loss of 95 jobs. [30-Apr-2009]
Vernalis is raising £24m in a share placing to fund clinical trials for its pharmaceuticals operations in Cambridge and Wokingham. [30-Apr-2009]
Elementis has confirmed plans to close its chromium plant in Stockton in June, with the loss of 138 jobs. [30-Apr-2009]
Croda International is to close its speciality chemicals plant at Bromborough on Merseyside, with the loss of 115 jobs. [30-Apr-2009]
Akzo Nobel is to shed up to 40 of the 1,000 jobs at its International Paints factory in Gateshead. [27-Apr-2009]
Morgan Ashurst has won a £12m contract from the National Institute for Biological Standards & Control to build a stem cell bank and influenza resource centre at South Mimms in Hertfordshire by December, and the site will employ 35 scientists. [27-Apr-2009]
GlaxoSmithKline is to acquire Stiefel Laboratories, the US dermatology company with 3,500 staff, for up to £2.4bn. [21-Apr-2009]
GlaxoSmithKline and Pfizer are to merge their HIV drugs operations into a new jointly-controlled company that will be based in London and employ several hundred staff. [20-Apr-2009]
Elementis Chromium is to announce the outcome of the strategic review of its Urlay Nook chemicals plant on Teesside in June, which could lead to the loss of up to 120 jobs. [20-Apr-2009]
Druckfarben has bought certain assets of Shackell Edwards & Co, the Stockport-based ink manufacturer, out of administration. [13-Apr-2009]
Piramal Healthcare is to close its pharmaceutical chemicals plant in Huddersfield next month with the loss of about 80 jobs, in order to transfer production to other sites in the UK and India. [13-Apr-2009]
Sygnature Chemical Services is planning to double the size of its pharmaceuticals research business at the BioCity centre in Nottingham over the next two years, and 15 chemists will be added to the 35-strong workforce. [09-Apr-2009]
Akzo Nobel has confirmed plans to transfer some of its paint production from Felling to Prudhoe in Northumberland, with the loss of 18 jobs. [06-Apr-2009]
Genzyme is to expand the 100-strong workforce at its Oxford-based biotechnology business with ten new jobs, having agreed a strategic partnership with Bayer. [02-Apr-2009]
Diurnal is to relocate its drug development business from Sheffield to Cardiff, having received a £0.25m investment from Finance Wales, Fusion IP and the Viking Fund. [02-Apr-2009]
Weilburger Coatings of Runcorn has acquired Trimite, the industrial coatings manufacturer with sites in Uxbridge, Bristol, Belfast and Glasgow. [02-Apr-2009]
The Department for Innovation, Universities and Skills (DIUS) has unveiled plans to make the Science & Innovation Campus at Daresbury into a new nationwide chemistry hub, with a £15m investment from the North West Regional Development Agency. [31-Mar-2009]
BioVex, the biotechnology company with offices in Oxford and the US, has raised a further £30m of capital to expand its business. [30-Mar-2009]
One NorthEast has unveiled plans for a £1.8m investment in the health care and life sciences sector, with the creation of 58 jobs at NHS Innovations North. [26-Mar-2009]
Deb is to shed 11 of the 95 jobs at its skincare and cleaning products factory in Belper. [26-Mar-2009]
Industrial Copolymers, the Lancashire-based resins and polymers manufacturer, is to change its name to Incorez, following the acquisition of its parent company Iotech Group by Sika. [26-Mar-2009]
UniChem is to shed up to 225 of the 5,000 jobs in its health and beauty products business, affecting sites in Exeter, Chessington, South Normanton and elsewhere. [26-Mar-2009]
Rohm & Haas is to close its emulsions manufacturing plant in Heckmondwike in July, with the loss of up to 43 jobs. [24-Mar-2009]
Oxford Gene Technology has acquired Sense Proteomic, the Maidenhead-based biotechnology firm with eight staff, taking its total workforce to more than 50. [19-Mar-2009]
Pivotal Laboratories, the York-based clinical trials and pharmaceutical services firm with 38 staff, has been acquired by ACM of the US for undisclosed terms. [17-Mar-2009]
Dales Engineering Services has acquired LJF Powder Coatings, the Aberdeen-based supplier of surface coatings with eight staff, for more than £1m. [17-Mar-2009]
AstraZeneca has appointed CB Richard Ellis to find a suitable 60,000 sq ft site for a new headquarters in London, and is expected to relocate from Stanhope Gate by 2010. [16-Mar-2009]
One NorthEast has assisted Nanjing Chuanbo Biotech of China in setting up a European headquarters for its drug development business at the International Business Centre in Gateshead, and a number of new jobs will be created. [12-Mar-2009]
The Biotechnology & Biological Sciences Research Council (BBSRC) is expected to announce plans for the development of a £13m Genome Analysis Centre at the Norwich Research Park, which could create up to 750 science jobs. [12-Mar-2009]
Merck is to acquire Schering-Plough for $41m, creating a global pharmaceuticals group with a combined UK workforce of almost 3,000 at sites including Hoddesdon, Cramlington, Welwyn Garden City, Newhouse and Milton Keynes. [11-Mar-2009]
Lab21 has acquired Biotec Laboratories, the Ipswich-based clinical diagnostics firm, for undisclosed terms. [11-Mar-2009]
Arkema of France is to close its polymer additives office in Solihull by the end of the year with the loss of 15 jobs, but its 11-strong UK sales team will be retained. [09-Mar-2009]
Penn Pharma is to invest £12m in the expansion of its biosciences operation in Tredegar, with the creation of 133 jobs. [05-Mar-2009]
Baxenden Chemicals is to shed up to 55 of the 90 jobs at its specialist coatings and paints factory in Droitwich. [05-Mar-2009]
Epistem Holdings of Manchester has agreed a multi-million-pound deal with Novartis of Switzerland to collaborate in the identification and development of new drug targets and therapeutics. [03-Mar-2009]
Bostik is planning to shed up to 29 of the 175 jobs at its sealants factory in Leicester, and a further 92 jobs could be lost at sites in Stafford and Chester. [26-Feb-2009]
Intercytex is seeking a buyer for its Manchester-based regenerative medicines business, having started a strategic review. [24-Feb-2009]
Clariant has confirmed plans to close its speciality chemicals plant in Horsforth, West Yorkshire, with the loss of 160 jobs, and is seeking a suitable site nearby to relocate the remaining 80 staff. [23-Feb-2009]
DxS is planning to expand the 60-strong workforce at its Manchester-based biotechnology business with 20 additional scientists and support staff this year. [23-Feb-2009]
Medisize is to close its medical devices factory in Sunderland in April, in order to transfer production to continental Europe. [23-Feb-2009]
One NorthEast has unveiled plans for a £1m investment in a new biochemical engineering laboratory at Newcastle University's School of Chemical Engineering. [23-Feb-2009]
Phytopharm is to shed 15 of the 40 jobs at its biotechnology research business in Godmanchester. [19-Feb-2009]
Oxford Instruments is to shed about 30 jobs in its Molecular Biotools division, following a fall in demand from pharmaceutical companies. [16-Feb-2009]
Schering-Plough is to invest about £20m in the expansion of its drug discovery research centre in Newhouse, Lanarkshire. [11-Feb-2009]
Avacta Group has acquired YorkTest Veterinary Services, the York-based veterinary laboratory services firm, for up to £0.8m. [10-Feb-2009]
Almac Group is to increase the 1,559-strong workforce at its pharmaceuticals research and development business in Northern Ireland with the recruitment of 54 additional staff over the next few months. [09-Feb-2009]
Dow is to shed up to 30 of the 90 jobs at its chemicals plant in Billingham, as part of a plan to cut 5,000 jobs from its 46,000-strong global workforce. [05-Feb-2009]
Quantum Specials, the County Durham-based manufacturer of bespoke drugs with more than 100 staff, has undergone a £32m management buy-out backed by Lloyds TSB Development Capital. [02-Feb-2009]
DuPont is to shed up to 35 of the 100 jobs at its chemicals plant in Whessoe Road, Darlington. [02-Feb-2009]
Jeyes is to create 50 jobs at its cleaning products factory in Thetford over the next three months, following the transfer of production from its Powder & Liquid Products site in Consett. [02-Feb-2009]
AstraZeneca has unveiled plans to shed a further 6,000 of the 65,000 jobs in its global pharmaceuticals business. [02-Feb-2009]
PZ Cussons is to close its fragrance chemicals plant in Ellesmere Port over the next few months, in order to relocate production and the 25 jobs to its new £26m site in Manchester. [29-Jan-2009]
Brunner Mond is to invest £18m at its Cheshire-based soda ash manufacturing operations, in order to cut energy costs and improve environmental performance. [29-Jan-2009]
Intercytex is planning to shed up to 50% of the 76 jobs at its regenerative medicine operations in Manchester and the US. [27-Jan-2009]
Unilever has acquired TIGI, the owner of Toni & Guy hair product ranges such as S-Factor, Bed Head and Catwalk, for £295m. [27-Jan-2009]
Huntsman Pigments is to close its titanium dioxide chemicals plant in Grimsby within two months, with the loss of more than 200 jobs. [26-Jan-2009]
GlaxoSmithKline is to acquire a portfolio of more than 50 medicines in Africa, Asia Pacific, Latin America and the Middle East from UCB of Belgium for £486m. [26-Jan-2009]
Croda International is to relocate its chemicals distribution business from Doncaster to an 83,500 sq ft unit being built at Capitol Park in Thorne. [23-Jan-2009]
Scottish Enterprise and the University of Edinburgh have announced funding of £12m to help commercialise the research work at the College of Medicine and enable new spin-off companies to locate at the Edinburgh BioQuarter project. [21-Jan-2009]
Johnson Matthey is to shed about 100 jobs at its chemicals plant in Royston, due to falling demand for emission control technology. [20-Jan-2009]
PolymerLatex is to stop production at its latex plant in Stoke Prior, Bromsgrove, with the loss of most of the 31 jobs. [16-Jan-2009]
Avacta Group has acquired Theragenetics, the medical diagnostics company with offices in London and the US, for up to £2m. [16-Jan-2009]
Invista Textiles is to close its nylon and polymer intermediaries plant at Wilton on Teesside, with the loss of up to 300 jobs. [15-Jan-2009]
Pfizer is to shed up to 240 of the 3,500 jobs at its pharmaceuticals research centre in Sandwich, Kent. [15-Jan-2009]
Fine Organics, the Billingham-based intermediary chemicals manufacturer with 218 staff, has undergone a management buy-out from Evonik Degussa of Germany for undisclosed terms. [13-Jan-2009]
MacDermid Autotype has shed up to 40 jobs at its chemical film coatings business in Wantage, Oxfordshire. [12-Jan-2009]
Avacta Group is to acquire Curidium Medica, the London-based biotechnology and diagnostics firm, for about £6.2m. [12-Jan-2009]
Yule Catto is to sell Oxford Chemicals, the Hartlepool-based manufacturer of aroma chemicals with 70 staff, to Frutarom for £8.2m. [06-Jan-2009]